Pooled data from 15 randomized treat-to-target trials in patients treated with basal insulin found that titrating basal doses above 0.5 units/kg did not result in further HbA1c or fasting plasma glucose improvement and increased the risk of hypoglycemia [3]. Here, INS is linked to Hypoglycemia.